Skip to main content
SpringerLink
Log in

T4, T3 and rT3 levels in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis

  • Short Communications
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

Thyronine (T4), triiodothyronine (T3), and reversetriiodothyronine (rT3) levels were evaluated in cerebrospinal fluid (CSF) and in serum of 12 patients with definite amyotrophic lateral sclerosis (ALS) by specific radioimmunoassays. Circulating microsomal and thyroglobulin antibodies were also evaluated. In all patients serum levels of T4, T3 and rT3 were within normal limits. In CSF, the rT3 levels were significantly elevated to 0.118 μg/l (mean), the T4 levels were not significantly elevated, and the T3 levels were below the detection limit of 0.03 μg/l. A correlation between the elevated rT3 levels in CSF and the severity or type of ALS could not be demonstrated by this study. The antithyroid antibodies (thyroglobulin antibodies, microsomal antibodies) showed normal titres and did not suggest disturbances of thyroid autoimmunity in the patients with ALS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Antel JP, Noronha A, Oder J (1982) Immunology of amyotrophic lateral sclerosis. In: Rowland LP (ed) Human motor neuron diseases. Raven Press, New York, pp 395–401

    Google Scholar 

  2. Appel StH, Stockton-Appel V, Stewart S, Kerman RH (1986) Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. Arch Neurol 43:234–238

    Google Scholar 

  3. Engel WK, Siddeque T, Nicoloff JT (1983) Effect on weakness and spasticity in ALS of thyrotropin releasing hormone. Lancet I:73–74

    Google Scholar 

  4. Fuhrmann H, Ködding R, Schliack H, Mühlen A von zur (1980) Jodthyronine im Liquor cerebrospinalis bei multipler Sklerose und 3 Vergleichskollektiven. Akt Neurol 7:103–107

    Google Scholar 

  5. Hagen GA, Solberg LA Jr (1974) Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology 95:1398–1410

    Google Scholar 

  6. Jackson IM, Adelman LS, Munsat TL, Forte S (1986) Amyotrophic lateral sclerosis: thyrotropin-releasing hormone and histidyl proline diketopiperazine in the spinal cord and cerebrospinal fluid. Neurology 36:1218–1223

    Google Scholar 

  7. Kaplan MM, Taft JA, Reichlin S, Munsat TL (1986) Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis. J Clin Endocrinol Metab 63:808–814

    Google Scholar 

  8. Kiessling WR (1982) Thyroid function in 44 patients with amyotrophic lateral sclerosis. Arch Neurol 39:241–242

    Google Scholar 

  9. Ködding R, Hesch RD, Mühlen A von zur (1976) A radioimmunoassay for reverse triiodothyronine. Acta Endocrinol (Copenh) [Suppl] 202:47–49

    Google Scholar 

  10. Ködding R, Janzen J, Schmidt E, Hesch RD (1976) Reverse triiodothyronine in liver disease. Lancet II:314

    Google Scholar 

  11. Mager J (1976) Myatrophe Lateralsklerose: Zwei ungewöhnliche Verläufe. Nervenarzt 47:261–264

    Google Scholar 

  12. Malin JP, Haas J, Kalies I (1986) Azetylcholin-Rezeptoren-Antikörper bei amyotropher Lateralsklerose (ALS). Joint Meeting of the German Neurological Society and the Neurological Societies of the Benelux-Countries. Aachen, 17–20 September 1986

  13. McMenamin J, Coxson M (1980) Motor neuron disease and hyperthyroid Graves disease: a chance association? J Neurol Neurosurg Psychiatry 43:46–49

    Google Scholar 

  14. Mitsumoto H, Salgado ED, Negroski D, Hanson MR (1986) Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials. Neurology 36:152–159

    Google Scholar 

  15. Mora JS, Munsat TL, Kao KP, Finison LJ (1986) Intrathecal administration of natural human interferon alpha in amyotrophic lateral sclerosis. Neurology 36:1137–1140

    Google Scholar 

  16. Nishikawa M, Inada M, Naito K (1982) 3,3′,5′-Triiodothyronine (reverse T3) in human cerebrospinal fluid. J Clin Endocrinol Metab 53:1030–1035

    Google Scholar 

  17. Thompson P, Burman KD, Wright FD (1982) Iodothyronine levels in human cerebrospinal fluid. J Clin Endocrinol Metab 54:653–655

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik mit Klinischer Neurophysiologie, Medizinische Hochschule Hannover, Konstanty-Gutschow-Strasse 8, D-3000, Hannover 61, Federal Republic of Germany

    J.-P. Malin & H. Fuhrmann

  2. Abteilung für Endokrinologie, Zentrum Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, Konstanty-Gutschow-Strasse 8, D-3000, Hannover 61, Federal Republic of Germany

    R. Ködding & A. von zur Mühlen

Authors
  1. J.-P. Malin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Ködding
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Fuhrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. von zur Mühlen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malin, JP., Ködding, R., Fuhrmann, H. et al. T4, T3 and rT3 levels in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. J Neurol 236, 57–59 (1989). https://doi.org/10.1007/BF00314221

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314221

Key words

Search

Navigation